GS-9820: Interim Phase Ib data

Interim data from 18 patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL) in the first 4 cohorts of the dose-escalation phase of an open-label, 3-part Dutch Phase Ib trial ...